RISE Life Science Corp. (CNSX:RLSC) announced that it has entered into a subscription receipt agreement for a private placement of subscription receipts at an issue price of $1,000 per subscription receipt on March 4, 2021. The receipts will be automatically converted, without payment of any additional consideration and without further action on the part of the holder thereof, into units of the company upon satisfaction or waiver of the escrow release conditions. Each unit will consist of a number of common shares in the capital of the company and a number of common share purchase warrants of the company The securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the closing date, in accordance with applicable securities laws. On the same date, the company issued 710 subscription receipts at an issue price of $1,000 per subscription receipt for gross proceeds of $710,000 in its first tranche.